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Abstract
Vitis coignetiae Pulliat (Yamabudo) is used as a health juice and wine based on the abun-
dant polyphenols and anthocyanins in its fruit. However, it is not known whether the leaves of
this plant confer similar benefits. This study investigated the hepatoprotective effects of aqueous
extracts from Vitis coignetiae Pulliat leaves (VCPL) in an animal model of nonalcoholic steato-
hepatitis (NASH). Rats were fed a choline-deficient high-fat diet for four weeks to generate fatty
livers. NASH was induced by oxidative stress loading. Ten weeks later, blood and liver samples
were collected from anesthetized animals and assessed biochemically, histologically, and histo-
chemically to determine the extent of oxidative stress injury and the overall effects of VCPL. Six-
week VCPL extract supplementation reduced serum levels of liver enzymes, decreased CYP2E1
induction, increased plasma antioxidant activities and delayed the progression of liver fibrosis.
The findings suggested that VCPL has strong radical-scavenging activity and may be beneficial in
preventing NASH progression.
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Vitis coignetiae Pulliat (Yamabudo) is used as a health juice and wine based on the abundant polyphe-
nols and anthocyanins in its fruit.  However,  it is not known whether the leaves of this plant confer 
similar beneﬁts.  This study investigated the hepatoprotective eﬀects of aqueous extracts from Vitis 
coignetiae Pulliat leaves (VCPL) in an animal model of nonalcoholic steatohepatitis (NASH).  Rats 
were fed a choline-deﬁcient high-fat diet for four weeks to generate fatty livers.  NASH was induced 
by oxidative stress loading.  Ten weeks later,  blood and liver samples were collected from anesthe-
tized animals and assessed biochemically,  histologically,  and histochemically to determine the extent 
of oxidative stress injury and the overall eﬀects of VCPL.  Six-week VCPL extract supplementation 
reduced serum levels of liver enzymes,  decreased CYP2E1 induction,  increased plasma antioxidant 
activities and delayed the progression of liver ﬁbrosis.  The ﬁndings suggested that VCPL has strong 
radical-scavenging activity and may be beneﬁcial in preventing NASH progression.
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onalcoholic steatohepatitis (NASH) is a chronic 
liver disease characterized by necroinﬂamma-
tory activity,  with nonspeciﬁc inﬂammatory inﬁltrates,  
hepatocyte ballooning with Malloryʼs hyaline,  and 
occasional ﬁbrosis [1].  The “two-hit theory” describes 
the most widely accepted mechanism for the progres-
sion of NASH [2].  We previously developed an ani-
mal model of NASH in the rat (Patent application No.  
PCT/JP2007/52477).  Our model rats with fatty liv-
ers developed methemoglobinemia following intermit-
tent administration of a nitrate compound [3].  We 
also demonstrated the excellent antioxidant activity of 
fermented green tea extracts,  which prevented the 
progression of NASH,  however,  due to the paucity of 
information on the potential eﬃcacy of antioxidant 
supplements in the treatment of NASH,  we focused on 
identifying candidate antioxidant(s) potentially suitable 
for clinical use against NASH.
　 Vitis coignetiae Pulliat (Yamabudo) is a grape variety 
native to the Japanese Islands.  Grape juice and wine 
made from this plant are taken by some for their 
health beneﬁts.  The ﬂesh and skin of the fruit contain 
abundant amounts of polyphenols and anthocyanins 
compared with other grape varieties [4].  Several 
biological properties have been attributed to Vitis 
coignetiae Pulliat including high free-radical-scavenging 
N
Acta Med.  Okayama,  2009
Vol.  63,  No.  2,  pp.  105ﾝ111
CopyrightⒸ 2009 by Okayama University Medical School.
Original Article http ://escholarship.lib.okayama-u.ac.jp/amo/
Received November 14, 2008 ; accepted December 24, 2008.
＊Corresponding author. Phone : ＋81ﾝ86ﾝ251ﾝ7973; Fax : ＋81ﾝ86ﾝ251ﾝ7973
E-mail : takayamaf@cc.okayama-u.ac.jp (F. Takayama)
1
Takayama et al.: Beneficial effects of Vitis coignetiae Pulliat leaves on nonalcoh
Produced by The Berkeley Electronic Press, 2009
activity and inhibition of photodecomposition of antho-
cyanin pigments [5].  We suspect that the same func-
tional compounds found in the fruit are also present in 
the Vitis coignetiae Pulliat leaves (VCPL),  despite the 
fact that there are no reports of similar biological 
eﬀects to date.  The aim of the present study was to 
determine whether VCPL prevents NASH progres-
sion in animals and to test whether oxidative stress 
provides “a second hit” and thus contributes to the 
development of the condition.
Materials and Methods
　 Chemicals. 5,5-Dimethyl-l-pyrroline N-oxide 
(DMPO) was purchased from Labotech (Tokyo,  
Japan).  Benzamidine hydrochloride and sodium nitrate 
were purchased from Nacalai Tesque (Kyoto,  Japan).  
All other reagents were obtained from Wako Pure 
Chemical Industries (Osaka,  Japan).  All chemicals 
used in our study were of the highest grade available.
　 Preparation of water extracts. Hiruzen 
Winery (Okayama,  Japan) provided the VCPL used in 
the present study.  Fresh red leaves (1,000g) were 
lyophilized to a ﬁnal 327g of dry leaves,  which were 
extracted with distilled water (bath ratio; 1 : 20) by 
stirring at room temperature for 30min.  The extract 
was ﬁltered and then solvent-evaporated to dry under 
reduced pressure in a rotary evaporator.  The resul-
tant water-extracted red powder (73.6g,  yield 7.4ｵ) 
was stored at －20°C for use in this study.
　 Animals and experimental design. Male 
Wistar rats,  6 weeks of age and weighing 160ﾝ170g 
were purchased from Shimizu Experimental Animals 
(Shizuoka,  Japan).  The animals were housed at the 
Animal Research Center of Okayama University in a 
temperature-controlled room (22±1°C) with a rela-
tive humidity of 50±10ｵ and a 12-h light/dark cycle 
(lights on at 8 : 00 a.m.).  The study protocol was 
approved by the Ethics Review Committee of Animal 
Experimentation of the Faculty of Pharmaceutical 
Science,  Okayama University.
　 We induced fatty liver in rats by feeding them a 
choline-deﬁcient high fat (CDHF) diet (Oriental Yeast) 
for 4 weeks.  The rats were divided at random into 5 
groups: the control group (n＝6) was fed standard 
chow for 4 weeks; the CDHF group (n＝6) was fed 
CDHF diet only for 4 weeks; the NASH group (n＝6) 
was fed CDHF diet for 4 weeks followed by intraperi-
toneal (i.p.) injections of nitrite (30mg/kg/day) for 6 
weeks,  the VCPL 100 group (n＝6) was fed CDHF 
diet for 4 weeks followed by i.p.  injections of nitrite 
at 30mg/kg/day for 6 weeks,  and was also orally 
administered VCPL at 100mg/kg/day (low dose) for 
6 weeks; and the VCPL 300 group (n＝6) was fed 
CDHF diet for 4 weeks followed by i.p.  injections of 
nitrite at 30mg/kg/day for 6 weeks,  and was orally 
administered VCPL at 300mg/kg/day (high dose).  At 
the end of the 10-week treatment period,  the rats 
fasted overnight and were sacriﬁced under deep anes-
thesia.  Liver and blood samples were taken to deter-
mine oxidative stress-related injury and the eﬃcacy of 
VCPL administration biochemically and histologically.  
The liver samples were ﬁxed in 20ｵ formalin or 
snap-frozen in liquid nitrogen for histological examina-
tion and to determine lipid peroxidation and antioxi-
dant activity.
　 Biochemical analyses. Alanine aminotrans-
ferase (ALT) and aspartate aminotransferase (AST) 
activities in plasma were measured using commercial 
enzyme assay kits (Wako).  Plasma alkaline phos-
phatase (ALP) levels were determined using standard 
assays.
　 Plasma SOD-like activity. Plasma superoxide 
dismutase (SOD)-like activity was measured using 
electron paramagnetic resonance (ESR) spectroscopy.  
Superoxide radicals were generated using a hypoxan-
thine-xanthine oxidase system.  CYPMPO (Radical 
Research,  Tokyo,  Japan) was used as an ESR spec-
troscopic spin-trapping reagent.  The signal intensity 
was conﬁrmed by the ratio of the heights of the inter-
nal manganese standard signal and the fourth of 8 
peaks from the CYPMPO-OOH spin adducts.  The 
conditions used were as follows: magnetic ﬁeld,  
331.5mT; power,  8mW; modulation frequency,  
9.41GHz; modulation amplitude,  1×0.1mT; re-
sponse time,  0.1s; amplitude,  790; sweep width,  
10mT; sweep time,  4min; room temperature [6ﾝ8].
　 Preparation of the liver microsomal frac-
tion. The liver mitochondria were isolated by dif-
ferential centrifugation of tissue homogenates as pre-
viously described [9].  In brief,  rats were 
transcardially perfused with ice-cooled 1.15ｵ KCl 
buﬀer containing 5mM benzamidine (pH7.4) via the 
inferior vena cava.  Liver tissue was then removed 
(6g) and homogenized in 18 volumes of ice-cooled 
5mM Tris-HCl buﬀer (pH7.4) containing 0.25mM 
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sucrose and 100mM KCl.  The mixture was centri-
fuged at 2,500rpm for 10min at 4°C.  The supernatant 
was collected after centrifugation at 9,000×g for 
20min at 4°C,  followed by another centrifugation at 
100,000×g for 60min at 4°C.  The resultant pellet 
containing the microsomal fraction was resuspended in 
the same buﬀer and stored at －80°C until analysis.  
Protein concentration was determined using a BCA kit 
(Pierce,  Rockford,  IL,  USA) with bovine serum 
albumin as a standard.
　Western blotting. Aliquots of liver micro-
somes (5µg) were placed in sample buﬀer (0.5M Tris-
HCl pH6.8,  10ｵ glycerol,  2ｵ SDS,  5ｵ 2-mercap-
toethanol,  and 0.05ｵ bromophenol blue) and 
denatured at 95°C for 5min.  The samples were sepa-
rated on Ready Gels (BioRad,  Hercules,  CA,  USA) 
then transferred to polyvinylidene ﬂuoride sheets 
(BioRad) using a transblot apparatus (BioRad).  The 
membranes were blocked overnight in 5ｵ nonfat milk 
dissolved in TBS-T buﬀer (Tris 50mM; 1.5ｵ 
NaCl; and 0.05ｵ Tween 20,  pH7.5),  before incubat-
ing with primary rabbit anti-human/rat cytochrome 
P450 enzyme (CYP2E1) polyclonal antibodies for 1h 
(1: 1,500; Chemicon International,  Temecula,  CA,  
USA).  The blots were then washed thoroughly in 
TBS-T buﬀer before incubating with a peroxidase-
conjugated secondary anti-rabbit IgG antibody 
(1: 5,000,  Santa Cruz Biotechnology,  Santa Cruz,  
CA,  USA) for 1h.  Visualization was performed with 
Chemiluminescence Luminol Reagent (Santa Cruz 
Biotechnology).
　 Histological examination. Paraﬃn-embedded 
tissues were sectioned at a thickness of 4µm and 
stained with hematoxylin and eosin (H&E).  The sec-
tions were also stained by Masson trichrome staining 
to identify ﬁbrosis.  Histological assessment of tissue 
morphology was performed using an Olympus light 
microscope (Olympus,  Tokyo,  Japan).
　 Statistical analyses. Statistical analysis was 
performed using GraphPad Prism (Version 
4.03; Graph Pad Software,  La Jolla,  CA,  USA) on 
untransformed data.  Data are expressed as mean ± 
standard error of the mean (SEM).  The groups were 
compared by an analysis of variance using the Turkey-
Kramer test,  and diﬀerences were considered signiﬁ-
cant when the probability was less than 0.05.
Results
　 Histological evaluation of experimental liver 
samples. Representative histological sections of 
the liver from each experimental group are shown in 
Fig.  1.  H&E staining of the liver sections showed 
hepatic macrovesicular steatosis in all CDHF-fed rats 
(Fig.  1).  We next evaluated the eﬀects of VCPL on 
liver ﬁbrogenesis in the diﬀerent treatment groups.  
No ﬁbrosis was noted in the livers of control rats fed 
standard chow compared with those fed CDHF alone.  
However,  the NASH rats showed advanced liver ste-
atosis,  ﬁbrosis,  and necrosis.  The addition of VCPL 
clearly attenuated the ﬁbrosis in all groups (Fig.  2).
　 Eﬀects of VCPL on plasma biochemical 
parameters. The AST and ALP levels in the 
NASH group were signiﬁcantly higher than those in 
the control group and the CDHF group.  The ALT 
levels were signiﬁcantly high in comparison with the 
controls.  VCPL supplementation at 300mg/kg sig-
niﬁcantly improved AST levels compared with the 
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Table 1　 Eﬀects of VCPL on biochemical markers
NASH
VCPL (mg/kg/day,  p.o)
Control
(n＝6)
CDHF
(n＝6)
0
(n＝6)
100
(n＝6)
300
(n＝6)
Biochemical markers (plasma)
　ALT (IU/L)  4.3±1.7 13.0±1.3a  13.7±2.6a  16.0±  4.4a 　7.8±1.1a
　AST (IU/L) 14.6±5.5 87.6±7.4a 127.8±6.6ab 142.1±17.2ab 102.3±4.9abc
　ALP (p-nitrophenol,  mM)  0.7±0.0  3.1±0.7a 　6.9±2.2ab 　3.1±  1.1ac 　3.0±0.8ad
Values represent the mean±S.E.M.  of 6 rats.  aP＜0.01 versus control,  bP＜0.01 versus CDHF,  cP＜0.05 versus NASH,  dP＜0.01 versus 
NASH.  VCPL,  Vitis coignetiae Pulliat leaves; control,  standard diets; CDHF,  choline-deﬁcient high-fat; NASH,  CDHF＋oxidative 
stress; VCPL 100,  NASH＋VCPL 100mg/kg; VCPL 300,  NASH＋VCPL 300mg/kg.
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Fig. 1　 Histological evaluation of rat liver.  Eﬀects of VCPL on liver structure were assessed by hematoxylin and eosin staining in con-
trol (A),  CDHF (B),  NASH (C),  NASH＋VCPL 100mg/kg (D) and NASH＋VCPL 300mg/kg (E) rats.  VCPL: Vitis coignetiae Pulliat 
leaves.  Data show typical results.  Scale bar＝500µm.
Ａ Ｂ Ｃ
Ｄ Ｅ
Fig. 2　 Eﬀects of VCPL on liver ﬁbrosis were examined by Masson Trichrome staining in control (A),  CDHF (B),  NASH (C),  NASH＋
VCPL 100mg/kg (D) and NASH＋VCPL 300mg/kg (E) rats.  VCPL: Vitis coignetiae Pulliat leaves.  Data show typical results.  Scale bar
＝500µm.
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NASH group,  although these parameters were still 
higher than in the control and CDHF groups.  
However,  there were no signiﬁcant diﬀerences 
between the NASH group and the VCPL 100 group.  
Moreover,  the ALP levels in VCPL 100 and VCPL 
300 were signiﬁcantly reduced in comparison with the 
NASH group (Table 1).
　 Eﬀects of VCPL on plasma antioxidant activ-
ity. The levels of plasma SOD-like activity in the 
NASH group were signiﬁcantly lower than those in the 
control group.  There were no signiﬁcant diﬀerences 
between the CDHF group and the NASH group.  
NASH rats treated with VCPL showed a signiﬁcant 
increase and had high plasma SOD-like activity com-
parable to that found in NASH rats (Fig.  3).
　 Eﬀects of VCPL on CYP2E1 induction in the 
liver microsomes. Western blot analysis was used 
to examine the induction of CYP2E1 expression with 
the development of NASH.  The 50-kDa CYP2E1 
protein was detected in all experimental groups.  The 
CYP2E1 expression in the NASH group was signiﬁ-
cantly higher than those in the control group and the 
CDHF group.  Moreover,  the CYP2E1 expression in 
the CDHF group was signiﬁcantly lower than those in 
the VCPL 100 group and the VCPL 300 group.  
NASH rats treated with VCPL at 300mg/kg showed 
signiﬁcantly lower CYP2E1 expression than the 
NASH group,  but it was not lower than the control 
and CDHF group levels.  There were no signiﬁcant 
diﬀerences between the NASH group and the VCPL 
100 group.  VCPL seemed to prevent CYP2E1 induc-
tion in a dose-dependent manner (Fig.  4).
Discussion
　 Free radical damage inducing oxidative stress has 
been proposed as a likely process underlying the pro-
gression to hepatocellular damage,  inﬂammation,  and 
ﬁbrosis [10].  It is therefore possible that nutritional 
support with antioxidants may be useful in preventing 
oxidative damage and thus the progression of NASH.  
There are many reports of food ingredients with 
antioxidant activities that can prevent clinical progres-
sion of NASH,  including green tea extracts [11],  
fermented green tea extracts [12] and N-acetylcys-
teine [13].  The present study showed that supplying 
VCPL prevented NASH progression through both the 
increase of plasma antioxidant activity and the attenu-
ation of microsomal CYP2E1 induction.  Moreover,  
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Fig. 3　 Eﬀects of VCPL on plasma SOD-like activity in the con-
trol,  CDHF,  NASH,  VCPL 100 and VCPL 300 groups by ESR.  
ESR spectra of the CYPMPO-OOH spin adducts obtained from 
hypoxanthine-xanthine oxidase systems in the control,  CDHF,  
NASH,  NASH＋VCPL 100mg/kg,  and NASH＋VCPL 300mg/kg 
groups.  VCPL: Vitis coignetiae Pulliat leaves.  Values represent 
the mean±S.E.M.  of 6 rats.  ＊indicates p＜0.05,  ＊＊indicates p＜
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Fig. 4　 Eﬀects of VCPL on CYP2E1 induction in the liver 
microsomes of the control,  CDHF,  NASH,  NASH+VCPL 100mg/
kg,  and NASH＋VCPL 300mg/kg groups.  Values represent the 
mean±S.E.M.  of 6 rats.  ＊indicates p＜0.05,  ＊＊indicates p＜
0.01.
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VCPL administration reduced the severe liver ﬁbrosis 
of NASH rats.  The degree of liver ﬁbrosis seemed to 
correlate to the liver index ((liver weight/body 
weight)×100) (data not shown).  We recognize VCPL 
as a novel functional food for the prevention of 
NASH.
　 Previous studies identiﬁed the pigments in the fruit 
and skin of Vitis coignetiae Pulliat as mostly malvidin-3,  
5-diglucoside and malvidin-3,  5-diglucoside coumarate 
[14].  These anthocyanins are generally included in the 
pericarp of American grape varieties.  Some studies 
have attributed anthocyanins with remarkable antioxi-
dant and oxygen radical-scavenging properties [15,  
16].  The present study therefore used only red leaves 
collected during autumn,  because these are presum-
ably rich in anthocyanins,  and would therefore be 
superior to the green leaves collected in summer in 
terms of the desired activities.  Previous studies on 
leaves from European grapes (Vitis vinifera L.) showed 
antihyperglycemic eﬀects in diabetic rats [17,  18] 
and hepatoprotective activities [19].  These ﬁndings 
would thus support the ﬁnding in this study that the 
anthocyanins in VCPL also conferred hepatoprotec-
tive eﬀects in NASH rats.  However,  this assumption 
is speculative,  and further studies are necessary to 
isolate and identify the VCPL components responsible 
for the observed eﬀects.
　 To clarify the role of VCPL on NASH progres-
sion,  we observed CYP2E1 protein expression in liver 
microsomes and antioxidant activity in plasma.  
CYP2E1 is a well-known source of oxidative stress 
and its levels are elevated in the liver of NASH 
patients [20].  CYP2E1 substrates include fatty acids 
and ketone bodies,  both of which could upregulate 
CYP2E1 activity to induce excess production of reac-
tive oxygen species [21,  22].  In fact,  the depletion 
of antioxidants in NASH patients leads to increased 
lipid peroxidation [23,  24].  The current results 
demonstrate that the decrease in plasma antioxidant 
activity was also more pronounced in NASH rats than 
in those with fatty liver only.  The administration of 
VCPL increased plasma SOD-like activity (Fig.  3).  
These results suggest that VCPL supplementation 
could regulate the balance of pro- and antioxidants.  
We expect that a lot of anthocyanins in VCPL may 
prevent NASH progression.  It could therefore be 
suggested that regulation of oxidative stress is an 
important ʻsecond hitʼ in the progression of NASH.  
Furthermore,  the induction of CYP2E1 was 
increased in NASH rats compared to those fed a 
CDHF diet,  suggesting some functional link to the 
further progression from steatosis to steatohepatitis.  
The excessive reactive oxygen species induced by 
CYP2E1 induction also may be a key factor in the 
process of NASH progression.
　 The exact mechanism behind the increased 
CYP2E1 protein expression in NASH rats compared 
to CDHF-fed rats remains unknown.  The administra-
tion of VCPL suppressed the microsomal CYP2E1 
induction and increased plasma antioxidant activity.  
Anthocyanins lower the total lipid and triglyceride 
levels in the livers of high-fat-fed mice relative to 
control mice fed the same high-fat diet without antho-
cyanins [25].  It is therefore possible that anthocya-
nins in the VCPL tested here might regulate CYP2E1 
via the lower liver content of total lipids,  which are 
CYP2E1 substrates,  thus delaying the progression of 
fatty liver to ﬁbrosis.
　 In summary,  VCPL ameliorated the progression of 
NASH by reducing CYP2E1 induction and increasing 
plasma antioxidant activity in rat models,  suggesting 
that oxidative stress-induced damage is associated with 
the progression of NASH.  Further studies are war-
ranted to determine the mechanisms underlying the 
beneﬁcial eﬀect of the antiﬁbrotic activity of VCPL 
on NASH,  as well as to assess the serial changes in 
mitochondrial function and liver architecture in NASH 
livers.
　 In conclusion,  this study demonstrated that the 
antioxidant activity of VCPL seems to prevent the 
progression of NASH by suppressing the induction of 
CYP2E1,  suggesting that VCPL is a novel functional 
food for the prevention of NASH.
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